INBS — Intelligent Bio Solutions Cashflow Statement
0.000.00%
Last trade - 00:00- $9.35m
- $8.34m
- $3.05m
- 28
- 22
- 27
- 14
Annual cashflow statement for Intelligent Bio Solutions, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.06 | -8.33 | -10.7 | -10.2 | -10.6 |
| Depreciation | |||||
| Non-Cash Items | 0.704 | 2.54 | 2.39 | 0.347 | 0.678 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.94 | 2.44 | 0.079 | -0.702 | -0.721 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -11.3 | -3.36 | -7.38 | -9.57 | -9.68 |
| Capital Expenditures | — | — | — | -0.005 | -0.232 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -0.88 | -0.694 | -0.216 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | -0.88 | -0.694 | -0.221 | -0.232 |
| Financing Cash Flow Items | -2 | 0 | -1.33 | 9.12 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 23.4 | 0 | 1.44 | 14.6 | 4.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 12.1 | -4.34 | -6.7 | 4.77 | -5.28 |